CONMED CORP (CNMD) Fundamental Analysis & Valuation

NYSE:CNMD • US2074101013

41.4 USD
-1.59 (-3.7%)
At close: Mar 5, 2026
41.4 USD
0 (0%)
After Hours: 3/5/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CNMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CNMD gets a fundamental rating of 5 out of 10. We evaluated CNMD against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of CNMD get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on CNMD. CNMD also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. CNMD Profitability Analysis

1.1 Basic Checks

  • In the past year CNMD was profitable.
  • In the past year CNMD had a positive cash flow from operations.
  • Of the past 5 years CNMD 4 years were profitable.
  • CNMD had a positive operating cash flow in each of the past 5 years.
CNMD Yearly Net Income VS EBIT VS OCF VS FCFCNMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

  • CNMD has a Return On Assets of 2.02%. This is in the better half of the industry: CNMD outperforms 74.46% of its industry peers.
  • CNMD's Return On Equity of 4.55% is fine compared to the rest of the industry. CNMD outperforms 76.63% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.23%, CNMD is in the better half of the industry, outperforming 73.37% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 8.91%.
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROIC 4.23%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
CNMD Yearly ROA, ROE, ROICCNMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • With a decent Profit Margin value of 3.42%, CNMD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • CNMD's Profit Margin has improved in the last couple of years.
  • CNMD has a Operating Margin of 8.39%. This is in the better half of the industry: CNMD outperforms 75.54% of its industry peers.
  • CNMD's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 54.59%, CNMD perfoms like the industry average, outperforming 53.26% of the companies in the same industry.
  • CNMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
CNMD Yearly Profit, Operating, Gross MarginsCNMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CNMD Health Analysis

2.1 Basic Checks

  • CNMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CNMD has been increased compared to 1 year ago.
  • Compared to 5 years ago, CNMD has more shares outstanding
  • Compared to 1 year ago, CNMD has an improved debt to assets ratio.
CNMD Yearly Shares OutstandingCNMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CNMD Yearly Total Debt VS Total AssetsCNMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • CNMD has an Altman-Z score of 1.89. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CNMD's Altman-Z score of 1.89 is in line compared to the rest of the industry. CNMD outperforms 59.24% of its industry peers.
  • CNMD has a debt to FCF ratio of 5.53. This is a neutral value as CNMD would need 5.53 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.53, CNMD is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
  • CNMD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.81, CNMD is doing worse than 71.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Altman-Z 1.89
ROIC/WACC0.49
WACC8.63%
CNMD Yearly LT Debt VS Equity VS FCFCNMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.14 indicates that CNMD has no problem at all paying its short term obligations.
  • CNMD has a Current ratio (2.14) which is in line with its industry peers.
  • A Quick Ratio of 1.01 indicates that CNMD should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.01, CNMD is doing worse than 77.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.01
CNMD Yearly Current Assets VS Current LiabilitesCNMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CNMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.82% over the past year.
  • CNMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.37% yearly.
  • The Revenue has been growing slightly by 5.18% in the past year.
  • The Revenue has been growing by 9.77% on average over the past years. This is quite good.
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%

3.2 Future

  • CNMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
  • Based on estimates for the next years, CNMD will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNMD Yearly Revenue VS EstimatesCNMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CNMD Yearly EPS VS EstimatesCNMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. CNMD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.98, which indicates a very decent valuation of CNMD.
  • Compared to the rest of the industry, the Price/Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 95.11% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.74, CNMD is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.14 indicates a reasonable valuation of CNMD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 95.65% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, CNMD is valued rather cheaply.
Industry RankSector Rank
PE 8.98
Fwd PE 9.14
CNMD Price Earnings VS Forward Price EarningsCNMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CNMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNMD is cheaper than 90.76% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 98.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.5
EV/EBITDA 10.95
CNMD Per share dataCNMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y4.92%
EPS Next 3Y7.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. CNMD Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.74%, CNMD has a reasonable but not impressive dividend return.
  • CNMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. CNMD pays more dividend than 95.65% of the companies in the same industry.
  • CNMD's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

  • The dividend of CNMD has a limited annual growth rate of 0.10%.
  • CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.1%
Div Incr Years0
Div Non Decr Years12
CNMD Yearly Dividends per shareCNMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 52.59% of the earnings are spent on dividend by CNMD. This is a bit on the high side, but may be sustainable.
  • CNMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.59%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
CNMD Yearly Income VS Free CF VS DividendCNMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
CNMD Dividend Payout.CNMD Dividend Payout, showing the Payout Ratio.CNMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CNMD Fundamentals: All Metrics, Ratios and Statistics

CONMED CORP

NYSE:CNMD (3/5/2026, 8:04:00 PM)

After market: 41.4 0 (0%)

41.4

-1.59 (-3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-28
Earnings (Next)04-28
Inst Owners114.3%
Inst Owner Change-5.24%
Ins Owners0.29%
Ins Owner Change0.47%
Market Cap1.28B
Revenue(TTM)1.37B
Net Income(TTM)47.05M
Analysts73.33
Price Target48.35 (16.79%)
Short Float %6.67%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend0.8
Dividend Growth(5Y)0.1%
DP52.59%
Div Incr Years0
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.3%
Min EPS beat(2)0.66%
Max EPS beat(2)5.94%
EPS beat(4)4
Avg EPS beat(4)5.44%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)8
Avg EPS beat(8)5.62%
EPS beat(12)11
Avg EPS beat(12)4.63%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-0.84%
Revenue beat(12)3
Avg Revenue beat(12)-0.05%
Revenue beat(16)4
Avg Revenue beat(16)-1.46%
PT rev (1m)-2.07%
PT rev (3m)-12.22%
EPS NQ rev (1m)-11.97%
EPS NQ rev (3m)-19.51%
EPS NY rev (1m)-1.27%
EPS NY rev (3m)-6.91%
Revenue NQ rev (1m)-5.99%
Revenue NQ rev (3m)-8.45%
Revenue NY rev (1m)-1.63%
Revenue NY rev (3m)-5.78%
Valuation
Industry RankSector Rank
PE 8.98
Fwd PE 9.14
P/S 0.93
P/FCF 8.5
P/OCF 7.51
P/B 1.24
P/tB N/A
EV/EBITDA 10.95
EPS(TTM)4.61
EY11.14%
EPS(NY)4.53
Fwd EY10.94%
FCF(TTM)4.87
FCFY11.77%
OCF(TTM)5.51
OCFY13.31%
SpS44.39
BVpS33.36
TBVpS-11.49
PEG (NY)N/A
PEG (5Y)0.55
Graham Number58.82
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROCE 5.74%
ROIC 4.23%
ROICexc 4.31%
ROICexgc 14.63%
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
FCFM 10.98%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
ROICexc(3y)5.4%
ROICexc(5y)4.81%
ROICexgc(3y)19.18%
ROICexgc(5y)17.21%
ROCE(3y)7.22%
ROCE(5y)6.44%
ROICexgc growth 3Y7.2%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y14.69%
ROICexc growth 5Y5.99%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Debt/EBITDA 4.4
Cap/Depr 26.66%
Cap/Sales 1.44%
Interest Coverage 4.54
Cash Conversion 90.02%
Profit Quality 320.65%
Current Ratio 2.14
Quick Ratio 1.01
Altman-Z 1.89
F-Score5
WACC8.63%
ROIC/WACC0.49
Cap/Depr(3y)23.78%
Cap/Depr(5y)24.75%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.51%
Profit Quality(3y)200.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
EBIT growth 1Y-44.98%
EBIT growth 3Y14.64%
EBIT growth 5Y11.42%
EBIT Next Year26.75%
EBIT Next 3Y14.3%
EBIT Next 5YN/A
FCF growth 1Y-1.95%
FCF growth 3Y135.18%
FCF growth 5Y23.98%
OCF growth 1Y2.23%
OCF growth 3Y72.25%
OCF growth 5Y21.49%

CONMED CORP / CNMD FAQ

What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNMD.


Can you provide the valuation status for CONMED CORP?

ChartMill assigns a valuation rating of 7 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.


How profitable is CONMED CORP (CNMD) stock?

CONMED CORP (CNMD) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CNMD stock?

The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 8.98 and the Price/Book (PB) ratio is 1.24.


What is the expected EPS growth for CONMED CORP (CNMD) stock?

The Earnings per Share (EPS) of CONMED CORP (CNMD) is expected to decline by -1.76% in the next year.